title: Is It Time to Reappraise Blood Pressure Thresholds and Targets? A Statement From the International Society of Hypertension-A Global Perspective.
authors.affiliation: From the Division of Cardiovascular Medicine, State University of New York, Downstate College of Medicine, New York (M.A.W.); International Centre for Circulatory Health, Imperial College London, United Kingdom (N.R.P.); MRC Unit for Hypertension and Cardiovascular Disease, Hypertension in Africa Research Team, North-West University, Potchefstroom, South Africa (A.E.S.); Department of Medicine, University of Melbourne, Victoria, Australia (L.M.B.); Department of Molecular Cardiovascular Biology and Pharmacology, Ehime University Graduate School of Medicine, Shitsukawa, Ehime, Japan (M.H.); Department of Research and Policy, Public Health Foundation of India and Centre for Chronic Disease Control, Haryana, India (D.P.); Arterial Hypertension and Metabolic Unit, University Hospital, Favaloro Foundation, Buenos Aires, Argentina (A.J.R.); The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.); Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, Montreal, Canada (E.L.S.); Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (R.M.T.).
authors.forename: Michael A
authors.initials: MA
authors.lastname: Weber
authors.affiliation: From the Division of Cardiovascular Medicine, State University of New York, Downstate College of Medicine, New York (M.A.W.); International Centre for Circulatory Health, Imperial College London, United Kingdom (N.R.P.); MRC Unit for Hypertension and Cardiovascular Disease, Hypertension in Africa Research Team, North-West University, Potchefstroom, South Africa (A.E.S.); Department of Medicine, University of Melbourne, Victoria, Australia (L.M.B.); Department of Molecular Cardiovascular Biology and Pharmacology, Ehime University Graduate School of Medicine, Shitsukawa, Ehime, Japan (M.H.); Department of Research and Policy, Public Health Foundation of India and Centre for Chronic Disease Control, Haryana, India (D.P.); Arterial Hypertension and Metabolic Unit, University Hospital, Favaloro Foundation, Buenos Aires, Argentina (A.J.R.); The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.); Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, Montreal, Canada (E.L.S.); Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (R.M.T.).
authors.forename: Neil R
authors.initials: NR
authors.lastname: Poulter
authors.affiliation: From the Division of Cardiovascular Medicine, State University of New York, Downstate College of Medicine, New York (M.A.W.); International Centre for Circulatory Health, Imperial College London, United Kingdom (N.R.P.); MRC Unit for Hypertension and Cardiovascular Disease, Hypertension in Africa Research Team, North-West University, Potchefstroom, South Africa (A.E.S.); Department of Medicine, University of Melbourne, Victoria, Australia (L.M.B.); Department of Molecular Cardiovascular Biology and Pharmacology, Ehime University Graduate School of Medicine, Shitsukawa, Ehime, Japan (M.H.); Department of Research and Policy, Public Health Foundation of India and Centre for Chronic Disease Control, Haryana, India (D.P.); Arterial Hypertension and Metabolic Unit, University Hospital, Favaloro Foundation, Buenos Aires, Argentina (A.J.R.); The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.); Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, Montreal, Canada (E.L.S.); Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (R.M.T.).
authors.forename: Aletta E
authors.initials: AE
authors.lastname: Schutte
authors.affiliation: From the Division of Cardiovascular Medicine, State University of New York, Downstate College of Medicine, New York (M.A.W.); International Centre for Circulatory Health, Imperial College London, United Kingdom (N.R.P.); MRC Unit for Hypertension and Cardiovascular Disease, Hypertension in Africa Research Team, North-West University, Potchefstroom, South Africa (A.E.S.); Department of Medicine, University of Melbourne, Victoria, Australia (L.M.B.); Department of Molecular Cardiovascular Biology and Pharmacology, Ehime University Graduate School of Medicine, Shitsukawa, Ehime, Japan (M.H.); Department of Research and Policy, Public Health Foundation of India and Centre for Chronic Disease Control, Haryana, India (D.P.); Arterial Hypertension and Metabolic Unit, University Hospital, Favaloro Foundation, Buenos Aires, Argentina (A.J.R.); The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.); Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, Montreal, Canada (E.L.S.); Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (R.M.T.).
authors.forename: Louise M
authors.initials: LM
authors.lastname: Burrell
authors.affiliation: From the Division of Cardiovascular Medicine, State University of New York, Downstate College of Medicine, New York (M.A.W.); International Centre for Circulatory Health, Imperial College London, United Kingdom (N.R.P.); MRC Unit for Hypertension and Cardiovascular Disease, Hypertension in Africa Research Team, North-West University, Potchefstroom, South Africa (A.E.S.); Department of Medicine, University of Melbourne, Victoria, Australia (L.M.B.); Department of Molecular Cardiovascular Biology and Pharmacology, Ehime University Graduate School of Medicine, Shitsukawa, Ehime, Japan (M.H.); Department of Research and Policy, Public Health Foundation of India and Centre for Chronic Disease Control, Haryana, India (D.P.); Arterial Hypertension and Metabolic Unit, University Hospital, Favaloro Foundation, Buenos Aires, Argentina (A.J.R.); The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.); Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, Montreal, Canada (E.L.S.); Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (R.M.T.).
authors.forename: Masatsugu
authors.initials: M
authors.lastname: Horiuchi
authors.affiliation: From the Division of Cardiovascular Medicine, State University of New York, Downstate College of Medicine, New York (M.A.W.); International Centre for Circulatory Health, Imperial College London, United Kingdom (N.R.P.); MRC Unit for Hypertension and Cardiovascular Disease, Hypertension in Africa Research Team, North-West University, Potchefstroom, South Africa (A.E.S.); Department of Medicine, University of Melbourne, Victoria, Australia (L.M.B.); Department of Molecular Cardiovascular Biology and Pharmacology, Ehime University Graduate School of Medicine, Shitsukawa, Ehime, Japan (M.H.); Department of Research and Policy, Public Health Foundation of India and Centre for Chronic Disease Control, Haryana, India (D.P.); Arterial Hypertension and Metabolic Unit, University Hospital, Favaloro Foundation, Buenos Aires, Argentina (A.J.R.); The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.); Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, Montreal, Canada (E.L.S.); Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (R.M.T.).
authors.forename: Dorairaj
authors.initials: D
authors.lastname: Prabhakaran
authors.affiliation: From the Division of Cardiovascular Medicine, State University of New York, Downstate College of Medicine, New York (M.A.W.); International Centre for Circulatory Health, Imperial College London, United Kingdom (N.R.P.); MRC Unit for Hypertension and Cardiovascular Disease, Hypertension in Africa Research Team, North-West University, Potchefstroom, South Africa (A.E.S.); Department of Medicine, University of Melbourne, Victoria, Australia (L.M.B.); Department of Molecular Cardiovascular Biology and Pharmacology, Ehime University Graduate School of Medicine, Shitsukawa, Ehime, Japan (M.H.); Department of Research and Policy, Public Health Foundation of India and Centre for Chronic Disease Control, Haryana, India (D.P.); Arterial Hypertension and Metabolic Unit, University Hospital, Favaloro Foundation, Buenos Aires, Argentina (A.J.R.); The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.); Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, Montreal, Canada (E.L.S.); Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (R.M.T.).
authors.forename: Agustin J
authors.initials: AJ
authors.lastname: Ramirez
authors.affiliation: From the Division of Cardiovascular Medicine, State University of New York, Downstate College of Medicine, New York (M.A.W.); International Centre for Circulatory Health, Imperial College London, United Kingdom (N.R.P.); MRC Unit for Hypertension and Cardiovascular Disease, Hypertension in Africa Research Team, North-West University, Potchefstroom, South Africa (A.E.S.); Department of Medicine, University of Melbourne, Victoria, Australia (L.M.B.); Department of Molecular Cardiovascular Biology and Pharmacology, Ehime University Graduate School of Medicine, Shitsukawa, Ehime, Japan (M.H.); Department of Research and Policy, Public Health Foundation of India and Centre for Chronic Disease Control, Haryana, India (D.P.); Arterial Hypertension and Metabolic Unit, University Hospital, Favaloro Foundation, Buenos Aires, Argentina (A.J.R.); The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.); Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, Montreal, Canada (E.L.S.); Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (R.M.T.).
authors.forename: Ji-Guang
authors.initials: JG
authors.lastname: Wang
authors.affiliation: From the Division of Cardiovascular Medicine, State University of New York, Downstate College of Medicine, New York (M.A.W.); International Centre for Circulatory Health, Imperial College London, United Kingdom (N.R.P.); MRC Unit for Hypertension and Cardiovascular Disease, Hypertension in Africa Research Team, North-West University, Potchefstroom, South Africa (A.E.S.); Department of Medicine, University of Melbourne, Victoria, Australia (L.M.B.); Department of Molecular Cardiovascular Biology and Pharmacology, Ehime University Graduate School of Medicine, Shitsukawa, Ehime, Japan (M.H.); Department of Research and Policy, Public Health Foundation of India and Centre for Chronic Disease Control, Haryana, India (D.P.); Arterial Hypertension and Metabolic Unit, University Hospital, Favaloro Foundation, Buenos Aires, Argentina (A.J.R.); The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.); Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, Montreal, Canada (E.L.S.); Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (R.M.T.).
authors.forename: Ernesto L
authors.initials: EL
authors.lastname: Schiffrin
authors.affiliation: From the Division of Cardiovascular Medicine, State University of New York, Downstate College of Medicine, New York (M.A.W.); International Centre for Circulatory Health, Imperial College London, United Kingdom (N.R.P.); MRC Unit for Hypertension and Cardiovascular Disease, Hypertension in Africa Research Team, North-West University, Potchefstroom, South Africa (A.E.S.); Department of Medicine, University of Melbourne, Victoria, Australia (L.M.B.); Department of Molecular Cardiovascular Biology and Pharmacology, Ehime University Graduate School of Medicine, Shitsukawa, Ehime, Japan (M.H.); Department of Research and Policy, Public Health Foundation of India and Centre for Chronic Disease Control, Haryana, India (D.P.); Arterial Hypertension and Metabolic Unit, University Hospital, Favaloro Foundation, Buenos Aires, Argentina (A.J.R.); The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.); Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, Montreal, Canada (E.L.S.); Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (R.M.T.). Rhian.Touyz@glasgow.ac.uk.
authors.forename: Rhian M
authors.initials: RM
authors.lastname: Touyz
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D001795:Blood Pressure Determination / Q000592:standards*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*
chemical_list: D000959:Antihypertensive Agents